Pharmacogenetic Risk for Adverse Reactions to Irinotecan in the Major Ethnic Populations of Singapore

The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome

Piter J. Bosma, Jayanta Roy Chowdhury, Conny Bakker et al. · New England Journal of Medicine · 1995 · 1.5K citations

Medicine, Genetics, Molecular Genetics +11

Genetic Variants in the <i>UDP-glucuronosyltransferase 1A1</i> Gene Predict the Risk of Severe Neutropenia of Irinotecan

Federico Innocenti, Samir D. Undevia, Lalitha Iyer et al. · Journal of Clinical Oncology · 2004 · 954 citations · Full text

Medicine, Oncology, Pharmacology +17

Racial variability in the UDP-glucuronosyltransferase 1 ( <i>UGT1A1</i> ) promoter: A balanced polymorphism for regulation of bilirubin metabolism?

Ernest Beutler, Terri Gelbart, Anna Demina · Proceedings of the National Academy of Sciences · 1998 · 852 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters

Janelle M. Hoskins, R. M. Goldberg, Peng Qu et al. · JNCI Journal of the National Cancer Institute · 2007 · 467 citations · Full text

Medicine, Hematology, Pharmacology +17

UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

E. Marcuello, Albert Altés, Anna Menoyo et al. · British Journal of Cancer · 2004 · 320 citations · Full text

Medicine, Oncology, Pharmacology +17